|Bid||30.01 x 1000|
|Ask||31.92 x 1200|
|Day's Range||29.60 - 32.16|
|52 Week Range||25.75 - 52.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
EMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 2021. The company’s management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. A webcast of the conference call can be accessed at https://investors.zymergen.com/. The webcast will be archived and available for replay for at least 90 days after the event. About Zymergen Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials. Investor ContactNiraj Javeriinvestors@zymergen.com Media ContactMike Dulinmdulin@zymergen.com502-777-2029
Biofacturing leader Zymergen (Nasdaq: ZY) today announced Aindrea Campbell is joining the company as Chief Manufacturing Officer, developing and leading Zymergen's global manufacturing and supply chain activities.
Enthusiasm for life-sciences stocks may be at an all-time high, but it's easy to lose your shirt when dealing with companies on the cutting edge like Calyxt (NASDAQ: CLXT) and Zymergen (NASDAQ: ZY). Both of these companies have huge potential for growth, but investors probably want to watch them from a safe distance for now. After discussing what to avoid, I'll also show you why Thermo Fisher Scientific (NYSE: TMO) is one of the best life-sciences stocks you can buy now.